Clinical Trial Update: A Single Dose Pharmaco-Diagnostic for Peripheral Nerve Continuity After Trauma [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating a single-dose pharmaco-diagnostic for peripheral nerve continuity after trauma was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Nerve Injury

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Nerve Injury | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2022-09-14